FC
EBS icon

FORA Capital’s Emergent Biosolutions EBS Stock Holding History

FORA Capital’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,290
Closed -$103K – 442
2024
Q3 		$103K Buy
+12,290
New +$112K 0.01% 418
2020
Q4 		– Sell
-2,515
Closed -$260K – 968
2020
Q3 		$260K Buy
+2,515
New +$271K 0.17% 132
2020
Q2 		– Sell
-1,647
Closed -$95K – 1008
2020
Q1 		$95K Buy
+1,647
New +$94.9K 0.02% 622

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OHA
Oak Hill Advisors New York $878M AUM 106.46% 1-Year Est. Return

FORA Capital's EBS Position: Q4 2024 in Review

FORA Capital sold out of Emergent Biosolutions (EBS) in Q4 2024, closing a stake of 12,290 shares — an estimated $103K sold.

FORA Capital first reported a position in EBS in Q1 2020 and held it in 3 quarters. The position peaked at $260K in Q3 2020. 156 funds tracked by Wall St. Rank hold EBS as of Q4 2024.

  • FORA Capital reported no remaining Emergent Biosolutions position as of Q4 2024 after selling out during the quarter.
  • FORA Capital sold 12,290 Emergent Biosolutions shares in Q4 2024, an estimated $103K.
  • FORA Capital first reported a position in Emergent Biosolutions in Q1 2020 and held it in 3 quarters.
  • FORA Capital's Emergent Biosolutions position peaked at $260K in Q3 2020.
  • 156 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2024.

Based on FORA Capital's 13F filing for Q4 2024, filed 14 Feb 2025.